Health
PSMA-Directed Therapies and Diagnostics Expand Their Scope in Prostate Cancer – Targeted Oncology
With the emergence of therapies that target PSMA, a cell surface transmembrane protein that is overexpressed in most prostate cancer cells, particularly in castration-resistant…
The December 2020 approval of the first agent for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)positive lesions in patients with prostate cancer, Gallium 68 PSMA-11 (Ga 68 PSMA-11), heralded an exciting new chapter in the diagnosis and treatment of metastatic castration-resistant prostate cancer (mCRPC). With the emergence of therapies that target PSMA, a cell surface transmembrane protein that is overexpressed in most prostate cancer cells, particularly…
-
Noosa News20 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business24 hours agoWhere will Nvidia stock be in 1 year?
-
Noosa News20 hours agoE-biker charged with riding dangerously, assaulting cop
-
Noosa News23 hours agoStar’s Brisbane casino has been in the headlines for months: What’s the latest?